Join Labroots for the highly anticipated 12th Annual Cancer Research & Oncology Virtual Event Series on October 2nd, 2024. This event will unite esteemed academic and industry experts and medical professionals worldwide. Watch free presentations on the latest breakthroughs and global cancer prevention, diagnosis, and treatment advancements across various cancer types.
Experience a dynamic 1-day program featuring engaging lectures, insightful discussions, and innovative posters designed to deepen your understanding of cutting-edge developments in the field. Discover how advancements in immunotherapy, personalized therapeutics, and targeted drug development are reshaping cancer care, leading to notable declines in mortality rates.
Cancer Research & Oncology 2024 is not just an event; it's your virtual gateway to exploring the forefront of cancer research and oncology. Register for free now to secure your spot and play a crucial role in staying ahead in the fight against cancer.
This year's tracks and focus areas include:
This event is accepting abstract submissions for on-demand educational talks on relevant topics. For more information, please contact our Senior Scientific Editor, Sarah Hoffman (sarah.hoffman@labroots.com).
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2024 Cancer Research & Oncology Virtual Event. Submission is free. Submit your abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global cancer research and immuno-oncology community with a high degree of interaction through live-streaming video and chat sessions.
Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 35 credits.
Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.
Connect with us!
When you attend the event remember to use the hashtag #LRcancer to follow the conversation and connect with other members of the global Cancer & Oncology Research community! Follow @Cancer_LR on Twitter and @CancerResearchandOncology.LR on Facebook to connect with our specialist Cancer & Oncology writers and stay up to date with the latest news in Cancer & Oncology Research.
Now, you can also join our Cancer Research & Oncology networking group on LinkedIn!
John R. Lewis Professor in Pathology, Director for Translational Health Disparities and Global Health Equity Research, Johns Hopkins University School of Medicine Division
Graduate Student, Pharmacology, UNC School of Medicine
Post-doc, Harvard T.H. Chan School of Public Health
Assistant Professor, School of Medicine, Cancer Biology Program, Wayne State University
Assistant Professor Endocrine Surgery, Director of Endocrine Surgery Research
HRI Scientist, Assistant Professor, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263
Chancellor's Professor, University of California, Irvine
PGY-3, Department of Pathology, Stanford Health Care
Associate Professor, Department of Pharmaceutical Sciences, School of Pharmacy
Associate Consultant, Department of Quantitative Health Sciences, Assistant Professor of Biomedical Informatics, Mayo Clinic College of Medicine and Science
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving ...
See moreDigital lab solutions for any laboratory need. Improve the quality of your life science research, optimize your workflow and increase productivity with eLabNext lab management software.
The Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and ...
See moreCeres Nanosciences is a privately held company, located in Northern Virginia, focused on incorporating its novel Nanotrap® particle technology into a range of diagnostic products and workflows. The Nanotrap® particle technology can improve diagnostic testing by capturing ...
See moreThe speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Kathleen (Katie) Kokolus is a research scientist at Roswell Park Comprehensive Cancer Center in Buffalo, NY. She received BS and MS degrees from Duquesne University before earning a PhD in Tumor Immunology from SUNY Buffalo. Dr. Kokolus also did a post-doctoral fellowship at ...
See moreDr. Yan Asmann is an Associate Professor of Biomedical Informatics at Mayo College of Medicine. Her research focuses on developing analytical algorithms and frameworks for multi-omics data mining, modeling, and integration. Dr. Asmann has applied these methods to study complex ...
See moreDr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...
See moreKeith L. Knutson, Ph.D., is a consultant in the Department of Immunology, Mayo Clinic in Florida, where he also serves as director of the Discovery and Translation Lab's Cancer Research Program. Dr. Knutson joined the staff of Mayo Clinic in 2005 and holds the academic rank of ...
See moreJonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...
See moreJohn Quackenbush is Professor of Computational Biology and Bioinformatics and Chair of the Department of Biostatistics at the Harvard TH Chan School of Public Health and Professor at the Dana-Farber Cancer Institute. John's PhD was in Theoretical Physics but a fellowship to work ...
See moreMontserrat Valdes is a highly skilled chemical engineer with a diverse background in research and industry. She holds a Master of Science degree in Chemical Engineering from the University of Saskatchewan and an Analytical Chemistry Diploma from the National Autonomous University ...
See moreRaoul S. Concepcion is the Chief Science Officer for U.S. Urology Partners in Nashville TN and Clinical Assistant Professor in the Department of Urology, Vanderbilt School of Medicine. Dr. Concepcion was a General Surgery and Urology Resident at Vanderbilt University School of ...
See moreDr. Sandro Matosevic is an associate professor in the College of Pharmacy at Purdue University, and is a member of the Purdue Center for Cancer Research. Dr. Matosevic runs an NIH-funded research program focused on the development and use of cell-based therapies with natural ...
See moreDr. David M. Albala graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr ...
See more